Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Nitroglycerin for Hemodynamic Response in CABG
NCT06637956Completed
- Start
- Jan 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of nitroglycerin in coronary artery disease (CAD) (2 arms). Primary endpoints: Mean Arterial Pressure, Heart Rate and 2 more. Started Jan 2024; status: completed.
02
Drugs
nitroglycerin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT06637956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06637956.